Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dysbiosis in Parkinson’s disease might be triggered by certain antibiotics
Gábor Ternák, Dániel Kuti, Krisztina Kovács
Medical Hypotheses (2020) Vol. 137, pp. 109564-109564
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders
Shokufeh Ghasemian Sorboni, Hanieh Shakeri Moghaddam, Reza Jafarzadeh Esfehani, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 1
Open Access | Times Cited: 312
Parkinson's Disease: A Multisystem Disorder
Helena Nunes Costa, A. Raquel Esteves, Nuno Empadinhas, et al.
Neuroscience Bulletin (2022) Vol. 39, Iss. 1, pp. 113-124
Closed Access | Times Cited: 80
Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome
Brian Bicknell, Ann Liebert, Thomas J. Borody, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9577-9577
Open Access | Times Cited: 65
Role of Gut Microbiota in Neurological Disorders and Its Therapeutic Significance
Prabhakar Tiwari, Rekha Dwivedi, Manisha Bansal, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1650-1650
Open Access | Times Cited: 49
The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment
Angelica Varesi, Lucrezia Irene Maria Campagnoli, Foroogh Fahmideh, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12289-12289
Open Access | Times Cited: 45
New hope for Parkinson's disease treatment: Targeting gut microbiota
Hongxia Fan, Shuo Sheng, Feng Zhang
CNS Neuroscience & Therapeutics (2022) Vol. 28, Iss. 11, pp. 1675-1688
Open Access | Times Cited: 43
Parkinson’s Disease and Photobiomodulation: Potential for Treatment
Brian Bicknell, Ann Liebert, Geoffrey Herkes
Journal of Personalized Medicine (2024) Vol. 14, Iss. 1, pp. 112-112
Open Access | Times Cited: 11
Microbial Amyloids: Polarisation-Optical Analysis
Levente Emödy, Josef Makovitzky
(2025), pp. 157-188
Closed Access
Microbiota Dysbiosis in Parkinson Disease—In Search of a Biomarker
Julia Maya Nowak, Mateusz Henryk Kopczyński, Andrzej Friedman, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2057-2057
Open Access | Times Cited: 21
Microbial signatures and therapeutic strategies in neurodegenerative diseases
Mlaak Rob, Mahmoud Yousef, Arun Prasath Lakshmanan, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117905-117905
Open Access
Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson’s disease
Ehraz Anis, Ao‐Ji Xie, Lena Brundin, et al.
Trends in Endocrinology and Metabolism (2021) Vol. 33, Iss. 2, pp. 147-157
Closed Access | Times Cited: 26
Remote Photobiomodulation Treatment for the Clinical Signs of Parkinson's Disease: A Case Series Conducted During COVID-19
Ann Liebert, Brian Bicknell, E‐Liisa Laakso, et al.
Photobiomodulation Photomedicine and Laser Surgery (2021) Vol. 40, Iss. 2, pp. 112-122
Closed Access | Times Cited: 23
Fiber deprivation and microbiome-borne curli shift gut bacterial populations and accelerate disease in a mouse model of Parkinson’s disease
Kristopher J Schmit, Pierre Garcia, Alessia Sciortino, et al.
Cell Reports (2023) Vol. 42, Iss. 9, pp. 113071-113071
Open Access | Times Cited: 10
Exploring Therapeutic Potential of Phytoconstituents as a Gut Microbiota Modulator in the Management of Neurological and Psychological Disorders
Prarit Chandel, Komal Thapa, Neha Kanojia, et al.
Neuroscience (2024) Vol. 551, pp. 69-78
Closed Access | Times Cited: 3
The link between the gut microbiota and Parkinson’s Disease: A systematic mechanism review with focus on α-synuclein transport
Sophie D. Nielsen, Nicola M. Pearson, Karin Seidler
Brain Research (2021) Vol. 1769, pp. 147609-147609
Closed Access | Times Cited: 17
Gut brain axis: an insight into microbiota role in Parkinson’s disease
Sara A. Moustafa, Shrouk M. Abdou, Abdelhameed Dawood, et al.
Metabolic Brain Disease (2021) Vol. 36, Iss. 7, pp. 1545-1557
Closed Access | Times Cited: 17
The role of environmental factors on sporadic Creutzfeldt-Jakob disease mortality: evidence from an age-period-cohort analysis
Angéline Denouel, Jean‐Philippe Brandel, Danielle Seilhean, et al.
European Journal of Epidemiology (2023) Vol. 38, Iss. 7, pp. 757-764
Open Access | Times Cited: 6
Antibiotic Consumption Patterns in European Countries Are Associated with the Prevalence of Parkinson’s Disease; the Possible Augmenting Role of the Narrow-Spectrum Penicillin
Gábor Ternák, Márton Németh, Martin Rozanovic, et al.
Antibiotics (2022) Vol. 11, Iss. 9, pp. 1145-1145
Open Access | Times Cited: 10
Is Gut Dysbiosis an Epicenter of Parkinson’s Disease?
Charul Rajput, Alika Sarkar, Nidhi Sachan, et al.
Neurochemical Research (2021) Vol. 46, Iss. 3, pp. 425-438
Closed Access | Times Cited: 12
Role of the Gut Microbiome and Bacterial Amyloids in the Development of Synucleinopathies
Nina P. Trubitsina, Anton B. Matiiv, Tatyana Rogoza, et al.
Biochemistry (Moscow) (2024) Vol. 89, Iss. 3, pp. 523-542
Closed Access | Times Cited: 1
The Role of The Gut Microbiome in Parkinson’s Disease
Amy Gallop, James Weagley, Saif-ur-Rahman Paracha, et al.
Journal of Geriatric Psychiatry and Neurology (2021) Vol. 34, Iss. 4, pp. 253-262
Closed Access | Times Cited: 10
Bacteria-Derived Protein Aggregates Contribute to the Disruption of Host Proteostasis
Alyssa C. Walker, Rohan Bhargava, Autumn S. Dove, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4807-4807
Open Access | Times Cited: 6
Possible Signaling Pathways in the Gut Microbiota–Brain Axis for the Development of Parkinson’s Disease Caused by Chronic Consumption of Food Additives
Melanie Verónica Martinez-Vega, Sebastián Galván-Menéndez-Conde, Verónica Freyre‐Fonseca
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 11, pp. 1950-1962
Closed Access | Times Cited: 2
Role of the Gut Microbiome and Bacterial Amyloids in the Development of Synucleinopathies (Review)
Nina P. Trubitsina, Anton B. Matiiv, Tatyana Rogoza, et al.
Биохимия (2024) Vol. 89, Iss. 3, pp. 487-508
Closed Access
Antibiotic Exposure and Risk of Parkinson Disease in South Korea
Minkyung Kim, Sun Jae Park, Young Jun Park, et al.
Neurology Clinical Practice (2024) Vol. 15, Iss. 1
Closed Access
Page 1 - Next Page

Scroll to top